Published in Infect Immun on December 01, 2000
Roles of galectins in infection. Nat Rev Microbiol (2009) 2.25
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev (2002) 2.20
Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol (2011) 2.03
Crossing the line: selection and evolution of virulence traits. PLoS Pathog (2006) 1.49
Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol (2009) 1.48
Gingival epithelial cell transcriptional responses to commensal and opportunistic oral microbial species. Infect Immun (2007) 1.44
Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am J Pathol (2009) 1.38
Peripatetic health-care workers as potential superspreaders. Proc Natl Acad Sci U S A (2009) 1.37
Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection. Infect Immun (2006) 1.28
Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans. Infect Immun (2009) 1.26
A new synthesis for antibody-mediated immunity. Nat Immunol (2011) 1.24
Complete genome sequence and lifestyle of black-pigmented Corynebacterium aurimucosum ATCC 700975 (formerly C. nigricans CN-1) isolated from a vaginal swab of a woman with spontaneous abortion. BMC Genomics (2010) 1.20
What is a host? Incorporating the microbiota into the damage-response framework. Infect Immun (2014) 1.05
Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun (2010) 1.05
"One-size-fits-all"? Optimizing treatment duration for bacterial infections. PLoS One (2012) 1.05
Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov (2013) 1.03
Interplay between innate and adaptive immunity in the development of non-infectious uveitis. Prog Retin Eye Res (2011) 0.98
Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings. Antimicrob Agents Chemother (2011) 0.97
Galectins as self/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox. Front Immunol (2012) 0.94
Structural and functional diversity of the lectin repertoire in teleost fish: relevance to innate and adaptive immunity. Dev Comp Immunol (2011) 0.93
Survival strategies of yeast and filamentous fungi against the antifungal protein AFP. J Biol Chem (2011) 0.90
What is a pathogen? Toward a process view of host-parasite interactions. Virulence (2014) 0.88
Computational prediction of molecular pathogen-host interactions based on dual transcriptome data. Front Microbiol (2015) 0.88
Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One (2009) 0.87
Evidence of melanoma in wild marine fish populations. PLoS One (2012) 0.85
Cryptic fungal infections: the hidden agenda of plant pathogens. Front Plant Sci (2014) 0.85
Strategies for the identification of virulence determinants in human pathogenic fungi. Curr Genet (2003) 0.81
Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. Future Microbiol (2013) 0.81
Determinants of virulence in the pathogenic fungi. Fungal Biol Rev (2007) 0.81
Stable transformation of an episomal protein-tagging shuttle vector in the piscine diplomonad Spironucleus vortens. BMC Microbiol (2008) 0.81
Lactobacillus plantarum favors the early emergence of fit and fertile adult Drosophila upon chronic undernutrition. J Exp Biol (2017) 0.80
Focal point theory models for dissecting dynamic duality problems of microbial infections. J Biomed Biotechnol (2008) 0.79
Comparison of virulence between Paracoccidioides brasiliensis and Paracoccidioides lutzii using Galleria mellonella as a host model. Virulence (2015) 0.79
Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia. Vet Res (2015) 0.78
Does Dark-Spot Syndrome Experimentally Transmit among Caribbean Corals? PLoS One (2016) 0.78
Widespread occurrence of bacterial human virulence determinants in soil and freshwater environments. Appl Environ Microbiol (2013) 0.78
Microbial Dysbiosis: Rethinking Disease in Marine Ecosystems. Front Microbiol (2016) 0.78
Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells. Front Immunol (2014) 0.77
The importance of multiparasitism: examining the consequences of co-infections for human and animal health. Parasit Vectors (2015) 0.77
Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One (2015) 0.77
Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital. J Clin Microbiol (2015) 0.77
Naegleria fowleri glycoconjugates with residues of α-D-mannose are involved in adherence of trophozoites to mouse nasal mucosa. Parasitol Res (2013) 0.76
Structural, functional, and evolutionary aspects of galectins in aquatic mollusks: From a sweet tooth to the Trojan horse. Fish Shellfish Immunol (2015) 0.76
Middle region of the Borrelia burgdorferi surface-located protein 1 (Lmp1) interacts with host chondroitin-6-sulfate and independently facilitates infection. Cell Microbiol (2015) 0.76
Antidiphtheria antibody responses in patients and carriers of Corynebacterium diphtheriae in the Arkhangelsk region of Russia. Clin Vaccine Immunol (2006) 0.76
Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice. J Eukaryot Microbiol (2009) 0.76
What is infectiveness and how is it involved in infection and immunity? BMC Immunol (2015) 0.75
Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study. Virus Res (2013) 0.75
Using Combined Diagnostic Test Results to Hindcast Trends of Infection from Cross-Sectional Data. PLoS Comput Biol (2016) 0.75
An Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming Discovery. Yale J Biol Med (2016) 0.75
In Silico Designing and Analysis of Inhibitors against Target Protein Identified through Host-Pathogen Protein Interactions in Malaria. Int J Med Chem (2016) 0.75
Staphylococcus aureus Lpl Lipoproteins Delay G2/M Phase Transition in HeLa Cells. Front Cell Infect Microbiol (2016) 0.75
The use of PCR/Electrospray Ionization-Time-of-Flight-Mass Spectrometry (PCR/ESI-TOF-MS) to detect bacterial and fungal colonization in healthy military service members. BMC Infect Dis (2016) 0.75
A stitch in time saves nine: closing the hole after removal of the aortic root cannula. J Cardiothorac Surg (2009) 0.75
Bacterial vaginosis: Etiology and modalities of treatment-A brief note. J Pharm Bioallied Sci (2011) 0.75
Appraisal of microbial evolution to commensalism and pathogenicity in humans. Clin Med Insights Gastroenterol (2013) 0.75
Nature and Consequences of Biological Reductionism for the Immunological Study of Infectious Diseases. Front Immunol (2017) 0.75
Meta-analysis of host response networks identifies a common core in tuberculosis. NPJ Syst Biol Appl (2017) 0.75
Vertebrate Reservoirs of Arboviruses: Myth, Synonym of Amplifier, or Reality? Viruses (2017) 0.75
Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94
Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis (1999) 10.30
Changing ecology of bacterial infections as related to antibacterial therapy. J Infect Dis (1970) 7.72
Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med (1976) 4.83
Microbial persistence. Yale J Biol Med (1958) 3.80
Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis (1994) 2.87
Ecology of Helicobacter pylori in the human stomach. J Clin Invest (1997) 2.77
Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun (1999) 2.69
The role of opportunistic bacteria in human disease. Annu Rev Microbiol (1977) 2.15
Retroviruses and primate evolution. Bioessays (2000) 1.96
Crisis in infectious diseases: time for a new paradigm? Clin Infect Dis (1996) 1.61
Oral Candida: clearance, colonization, or candidiasis? J Dent Res (1995) 1.54
Microbial opportunism in clinical medicine. J Natl Med Assoc (1974) 1.52
Autochthonous and pathogenic colonization of animal tissues by bacteria. Can J Microbiol (1981) 1.43
Antibiotic-induced suprainfection. J Infect Dis (1969) 1.42
Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen-producing strains of Staphylococcus aureus. Infect Immun (1984) 1.41
Danger - pathogen on the premises! Immunological tolerance. Curr Biol (1996) 1.19
Bacterial virulence and pathogenesis: an overview. Rev Infect Dis (1983) 1.17
Benefit and mischief from commensal bacteria. J Clin Pathol (1973) 1.16
Pathogenicity and virulence: another view. Clin Microbiol Rev (1988) 1.07
History of opportunistic infection in the immunocompromised host. Clin Infect Dis (1993) 0.98
Streptococcal pharyngitis: the carrier state, definition, and management. Pediatr Ann (1998) 0.97
Emerging and reemerging infectious diseases: a multidisciplinary perspective. Am J Med Sci (1998) 0.92
IgE, IgA, and IgG responses to common yeasts in atopic patients. Allergy (1998) 0.92
Virulence factors in the colonization and persistence of bacteria in the airways. Am J Respir Crit Care Med (1995) 0.90
Prevalence of oral colonization with Candida albicans and anti-C. albicans IgA in the saliva of normal children and children with acute lymphoblastic leukaemia. Mycopathologia (1984) 0.89
Pathogen or commensal? Arch Dis Child (1980) 0.88
The revival of interest in mechanisms of bacterial pathogenicity. Biol Rev Camb Philos Soc (1995) 0.85
Opportunistic infections. Heart Lung (1976) 0.83
What is infection? Am J Surg (1994) 0.83
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun (1999) 2.69
Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am J Med (1992) 2.28
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A (1993) 1.86
Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J Virol (1995) 1.53
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. Clin Exp Immunol (1995) 1.45
Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect Immun (1994) 1.34
Extracellular proteins of Cryptococcus neoformans and host antibody response. Infect Immun (1997) 1.17
Antifungal activity of a human antiglucuronoxylomannan antibody. Clin Diagn Lab Immunol (1998) 1.16
Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies. Infect Immun (1996) 1.02
Vaccination against infectious disease following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2001) 1.00
Adjunctive immune therapy for fungal infections. Clin Infect Dis (2001) 0.97
Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Infect Immun (1997) 0.92
Fc gammaRIIa polymorphism in human immunodeficiency virus-infected children with invasive pneumococcal disease. Pediatr Res (1997) 0.77
Primary group A streptococcal peritonitis in adults. Am J Med (1990) 0.77
Pneumococcal vaccine with unknown vaccination status. Semin Dial (2000) 0.75